SCHEMBL24374002

SCHEMBL24374002

C=C(C)C/C=C\C=C(/C/C=C\C)CCCN

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24075459 0.72
SCHEMBL736047 0.72
SCHEMBL736046 0.72
SCHEMBL11833456 0.66 HSD17B10 (0.30)
SCHEMBL11833451 0.66 HSD17B10 (0.30)
SCHEMBL13093832 0.66 TSHR (0.31)
SCHEMBL27434511 0.65 CYP1A2 (0.32)
SCHEMBL921645 0.63
SCHEMBL27343852 0.60 CES1 (0.36)
SCHEMBL14451906 0.60 CYP1A2 (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3988544-A1 ISOQUINOLINONE DERIVATIVES SERVING AS ROCK PROTEIN KINASE INHIBITORS AND USE THEREOF Guangzhou Ocusun Ophthalmic Biotechnology Co., Ltd. (CN) 2022-04-27 EP disclosed